1163302-36-0Relevant articles and documents
New developments for the design, synthesis and biological evaluation of potent SARS-CoV 3CLpro inhibitors
Regnier, Thomas,Sarma, Diganta,Hidaka, Koushi,Bacha, Usman,Freire, Ernesto,Hayashi, Yoshio,Kiso, Yoshiaki
scheme or table, p. 2722 - 2727 (2010/01/16)
A series of trifluoromethyl, benzothiazolyl or thiazolyl ketone-containing peptidic compounds as SARS-CoV 3CL protease inhibitors were developed and their potency was evaluated by in vitro protease inhibitory assays. Three candidates had encouraging resul